E&T Magazine, the official publication of the Institution of Engineering and Technology (IET), presented its "Future Unicorn" award to Donisi Health (Donisi), an Israeli medtech company that helps patients with Congestive Heart Failure (CHF) and other chronic diseases monitor their health status.
Follow Israel Hayom on Facebook and Twitter
Based upon FDA-cleared technology and backed by 11 granted patents, Donisi's AI-based system detects and analyzes multiple health bio-indicators simultaneously, delivering clinically meaningful insights and notifications of changes in key health indicators.
"We are honored to receive this prestigious award from E&T Magazine confirming Donisi is on the right path to bringing a disruptive solution to meaningfully impact patient health," said Donisi CEO Yair Brosh.
"We are focused on applying our breakthrough technology to address real unmet needs, starting with the high readmission rate for CHF patients leaving the hospital who need to monitor pulmonary congestion at home. We greatly appreciate this recognition of our team's efforts," Brosh said.
